{"cursor":"7966","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed verifiedrevid = 461750802 IUPAC_name = N-(4-{1-[(2,4-diaminopteridin-6-yl)methyl]but-3-yn-1-yl}benzoyl)-\n| L -glutamic acid image = Pralatrexate.png width = 300\n\n\n| tradename = Folotyn Drugs.com = licence_US = Pralatrexate pregnancy_AU =  pregnancy_US = \n| pregnancy_category = D legal_AU =  legal_CA =  legal_UK =  legal_US = Rx-only\n| legal_status = routes_of_administration = Intravenous\n\n\n| bioavailability = protein_bound = metabolism = elimination_half-life =\n| excretion =\n\n\n| CAS_number_Ref = CAS_number = 146464-95-1 ATC_prefix = L01 ATC_suffix = BA05\n| PubChem = 148121 DrugBank_Ref = DrugBank = ChEBI_Ref = ChEBI = 71223\n| ChemSpiderID_Ref = ChemSpiderID = 130578 UNII_Ref = UNII = A8Q8I19Q20\n| ChEMBL_Ref = ChEMBL = 1201746\n\n\n| C=23 | H=23 | N=7 | O=5 molecular_weight = 477.47 g/mol smiles =\n| O=C(O)[C@@H](NC(=O)c1ccc(cc1)C(CC#C)Cc2nc3c(nc2)nc(nc3N)N)CCC(=O)O InChI = 1/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-\n| 13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-\n| 10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1 InChIKey =\n| OGSBUKJUDHAQEA-WMCAAGNKBV StdInChI_Ref = StdInChI = 1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-\n| 13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-\n| 10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1\n| StdInChIKey_Ref = StdInChIKey = OGSBUKJUDHAQEA-WMCAAGNKSA-N\n}}\n\n'Pralatrexate' (brand name 'Folotyn') is an anti-cancer therapy. [http://ir.allos.com/phoenix.zhtml?c=125475&p=irol-\nnewsArticle&ID=1277828&highlight], Allos Therapeutics Press Release, âAllos\nTherapeutics' Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer\nCell Linesâ. It is the first drug approved as a treatment for patients\nwith relapsed or refractory peripheral T-cell lymphoma, or PTCL [http://ir.allos.com/phoenix.zhtml?c=125475&p=irol-\nnewsArticle&ID=1335492&highlight], Allos Therapeutics Press Release, âAllos\nTherapeutics' FOLOTYN(TM) First and Only FDA-Approved Therapy for Relapsed or\nRefractory Peripheral T-cell Lymphomaâ. â a biologically diverse group of\naggressive blood cancers that have a poor prognosis.\n","linknr":423,"url":"10-propargyl-10-deazaaminopterin","recorded":1375090107,"links":["/w/index.php?title=Pralatrexate&action=edit","/w/index.php?title=Pralatrexate&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","/wiki/Pralatrexate","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","/w/index.php?title=10-propargyl-10-deazaaminopterin&redirect=no","#mw-navigation","#p-search","/wiki/File:Pralatrexate.png","//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Pralatrexate.png/300px-Pralatrexate.png","/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/pralatrexate.html","/wiki/Regulation_of_therapeutic_goods","/wiki/U.S._Food_and_Drug_Administration","http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Pralatrexate&SearchType=BasicSearch","/wiki/Pregnancy_category","/wiki/Regulation_of_therapeutic_goods","/wiki/Prescription_drug","/wiki/United_States","/wiki/Route_of_administration","/wiki/Intravenous_therapy","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=146464-95-1&rn=1","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L01","http://www.whocc.no/atc_ddd_index/?code=L01BA05","/wiki/PubChem","http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=148121","/wiki/ChemSpider","http://www.chemspider.com/Chemical-Structure.130578","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A8Q8I19Q20","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEBI","https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71223","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201746","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Molecular_mass","/wiki/Simplified_molecular_input_line_entry_specification","/wiki/International_Chemical_Identifier","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461750802&page2=Pralatrexate","#cite_note-PR-1","/wiki/Peripheral_T-cell_lymphoma","#cite_note-PR2-2","#cite_note-PR2-2","#Approval","#Mechanism","#Discovery","#References","#External_links","/w/index.php?title=Pralatrexate&action=edit&section=1","/wiki/Food_and_Drug_Administration","#cite_note-PR2-2","#cite_note-PR3-3","#cite_note-PR2-2","/wiki/Clinical_trials","#cite_note-PR4-4","/w/index.php?title=Pralatrexate&action=edit&section=2","/wiki/Antifolate","/wiki/Folate","/wiki/Cancer_cells","#cite_note-PR-1","#cite_note-PR-1","/wiki/Antimetabolites","#cite_note-PR5-5","/wiki/Metabolites","#cite_note-PR5-5","#cite_note-PR-1","#cite_note-PR5-5","/w/index.php?title=Pralatrexate&action=edit&section=3","/wiki/SRI_International","/wiki/Chemotherapies","/wiki/Tumor_cells","#cite_note-PR-1","#cite_note-PR6-6","#cite_note-PR6-6","#cite_note-PR8-7","#cite_note-PR7-8","#cite_note-9","/w/index.php?title=Pralatrexate&action=edit&section=4","#cite_ref-PR_1-0","#cite_ref-PR_1-1","#cite_ref-PR_1-2","#cite_ref-PR_1-3","#cite_ref-PR_1-4","http://ir.allos.com/phoenix.zhtml?c=125475&p=irol-newsArticle&ID=1277828&highlight","#cite_ref-PR2_2-0","#cite_ref-PR2_2-1","#cite_ref-PR2_2-2","#cite_ref-PR2_2-3","http://ir.allos.com/phoenix.zhtml?c=125475&p=irol-newsArticle&ID=1335492&highlight","#cite_ref-PR3_3-0","http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm","#cite_ref-PR4_4-0","http://seekingalpha.com/article/203251-allos-therapeutics-inc-q1-2010-earnings-call-transcript","#cite_ref-PR5_5-0","#cite_ref-PR5_5-1","#cite_ref-PR5_5-2","http://www.psychiatrictimes.com/display-old/article/10165/1166026","#cite_ref-PR6_6-0","#cite_ref-PR6_6-1","http://www.mskcc.org/mskcc/html/95988.cfm","#cite_ref-PR8_7-0","http://www.cancer.gov/ncicancerbulletin/102009/page4","#cite_ref-PR7_8-0","http://www.sri.com/newsroom/press-releases/fda-approves-pralatrexate","/wiki/SRI_International","#cite_ref-9","http://www.bizjournals.com/denver/news/2012/09/05/purchase-of-allos-therapeutics-is.html","/wiki/Denver_Business_Journal","/w/index.php?title=Pralatrexate&action=edit&section=5","http://www.clinicaltrials.gov/ct2/results?term=pralatrexate","http://www.folotyn.com/","http://www.focusonptcl.com/","http://www.getasapinfo.com/","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template_talk:Intracellular_chemotherapeutic_agents","//en.wikipedia.org/w/index.php?title=Template:Intracellular_chemotherapeutic_agents&action=edit","/wiki/Chemotherapy_(oncology)","/wiki/Antineoplastic","/wiki/ATC_code_L01","/wiki/Spindle_poison","/wiki/Mitotic_inhibitor","/wiki/M_phase","/wiki/Microtubule","/wiki/Catharanthus#Vinca_alkaloids","/wiki/Vinblastine","/wiki/Vincristine","/wiki/Vinflunine","/wiki/Vindesine","/wiki/Vinorelbine","/wiki/Taxane","/wiki/Cabazitaxel","/wiki/Docetaxel","/wiki/Larotaxel","/wiki/Ortataxel","/wiki/Paclitaxel","/wiki/Tesetaxel","/wiki/Epothilone","/wiki/Ixabepilone","/wiki/DNA_replication","/wiki/Antimetabolite","/wiki/S_phase","/wiki/Antifolate","/wiki/Dihydrofolate_reductase_inhibitor","/wiki/Aminopterin","/wiki/Methotrexate","/wiki/Pemetrexed","/wiki/Thymidylate_synthase_inhibitor","/wiki/Raltitrexed","/wiki/Pemetrexed","/wiki/Purine_analogue","/wiki/Adenosine_deaminase_inhibitor","/wiki/Pentostatin","/wiki/Halogenated","/wiki/Ribonucleotide_reductase_inhibitor","/wiki/Cladribine","/wiki/Clofarabine","/wiki/Fludarabine","/wiki/Nelarabine","/wiki/Thiopurine","/wiki/Tioguanine","/wiki/Mercaptopurine","/wiki/Pyrimidine_analogue","/wiki/Thymidylate_synthase_inhibitor","/wiki/Fluorouracil","/wiki/Capecitabine","/wiki/Tegafur","/wiki/Carmofur","/wiki/Floxuridine","/wiki/DNA_polymerase_inhibitor","/wiki/Cytarabine","/wiki/Ribonucleotide_reductase_inhibitor","/wiki/Gemcitabine","/wiki/Hypomethylating_agent","/wiki/Azacitidine","/wiki/Decitabine","/wiki/Deoxyribonucleotide","/wiki/Ribonucleotide_reductase_inhibitor","/wiki/Hydroxycarbamide","/wiki/Topoisomerase_inhibitor","/wiki/S_phase","/wiki/Topoisomerase_I#Inhibition","/wiki/Camptotheca","/wiki/Camptothecin","/wiki/Topotecan","/wiki/Irinotecan","/wiki/Rubitecan","/wiki/Belotecan","/wiki/Topoisomerase_II#Inhibition","/wiki/American_Mayapple","/wiki/Etoposide","/wiki/Teniposide","/wiki/Topoisomerase_II#Inhibition","/wiki/Intercalation_(chemistry)","/wiki/Anthracycline","/wiki/Aclarubicin","/wiki/Daunorubicin","/wiki/Doxorubicin","/wiki/Epirubicin","/wiki/Idarubicin","/wiki/Amrubicin","/wiki/Pirarubicin","/wiki/Valrubicin","/wiki/Zorubicin","/wiki/Anthracenedione","/wiki/Mitoxantrone","/wiki/Pixantrone","/wiki/Crosslinking_of_DNA","/wiki/Cell-cycle_nonspecific_antineoplastic_agents","/wiki/Alkylating_antineoplastic_agent","/wiki/Nitrogen_mustard","/wiki/Mechlorethamine","/wiki/Cyclophosphamide","/wiki/Ifosfamide","/wiki/Trofosfamide","/wiki/Chlorambucil","/wiki/Melphalan","/wiki/Prednimustine","/wiki/Bendamustine","/wiki/Uramustine","/wiki/Estramustine","/wiki/Nitrosourea","/wiki/Carmustine","/wiki/Lomustine","/wiki/Semustine","/wiki/Fotemustine","/wiki/Nimustine","/wiki/Ranimustine","/wiki/Streptozotocin","/wiki/Alkyl_sulfonate","/wiki/Busulfan","/wiki/Mannosulfan","/wiki/Treosulfan","/wiki/Aziridine","/wiki/Carboquone","/wiki/ThioTEPA","/wiki/Triaziquone","/wiki/Triethylenemelamine","/wiki/Platinum-based_antineoplastic","/wiki/Carboplatin","/wiki/Cisplatin","/wiki/Nedaplatin","/wiki/Oxaliplatin","/wiki/Satraplatin","/wiki/Alkylating_antineoplastic_agent#Nonclassical","/wiki/Hydrazine","/wiki/Procarbazine","/wiki/Triazene","/wiki/Dacarbazine","/wiki/Temozolomide","/wiki/Altretamine","/wiki/Mitobronitol","/wiki/Pipobroman","/wiki/Intercalation_(chemistry)","/wiki/Streptomyces","/wiki/Actinomycin","/wiki/Bleomycin","/wiki/Mitomycin","/wiki/Plicamycin","/wiki/Photosensitizer","/wiki/Photodynamic_therapy","/wiki/D-Aminolevulinic_acid","/wiki/Methyl_aminolevulinate","/wiki/Efaproxiral","/wiki/Porphyrin","/wiki/Porfimer_sodium","/wiki/Talaporfin","/wiki/Temoporfin","/wiki/Verteporfin","/wiki/Enzyme_inhibitor","/wiki/Farnesyltransferase_inhibitor","/wiki/Tipifarnib","/wiki/Cyclin-dependent_kinase","/wiki/Protein_kinase_inhibitor","/wiki/Alvocidib","/wiki/Seliciclib","/wiki/Proteasome_inhibitor","/wiki/Bortezomib","/wiki/Carfilzomib","/wiki/Phosphodiesterase_inhibitor","/wiki/Anagrelide","/wiki/IMP_dehydrogenase","/wiki/Tiazofurin","/wiki/Lipoxygenase_inhibitor","/wiki/Masoprocol","/wiki/PARP_inhibitor","/wiki/Olaparib","/wiki/Histone_deacetylase_inhibitor","/wiki/Panobinostat","/wiki/Vorinostat","/wiki/Romidepsin","/wiki/Receptor_antagonist","/wiki/Endothelin_receptor_antagonist","/wiki/Atrasentan","/wiki/Retinoid_X_receptor","/wiki/Bexarotene","/wiki/Sex_steroid","/wiki/Testolactone","/wiki/Amsacrine","/wiki/Trabectedin","/wiki/Retinoid","/wiki/Alitretinoin","/wiki/Tretinoin","/wiki/Arsenic_trioxide","/wiki/Asparagine","/wiki/Asparaginase","/wiki/Pegaspargase","/wiki/Celecoxib","/wiki/Demecolcine","/wiki/Elesclomol","/wiki/Elsamitrucin","/wiki/Etoglucid","/wiki/Lonidamine","/wiki/Lucanthone","/wiki/Mitoguazone","/wiki/Mitotane","/wiki/Oblimersen","/wiki/Omacetaxine_mepesuccinate","/wiki/Eribulin","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Neoplasm","/wiki/Template:Tumor_suppressor_genes_and_oncogenes","/wiki/Template:Tumor_markers","/wiki/Template:Tumors","/wiki/Template:Eponymous_medical_signs_for_oncology","/wiki/Template:Paraneoplastic_syndromes","/wiki/ATC_code_L","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Pralatrexate&oldid=563767816","/wiki/Help:Categories","/wiki/Category:Dihydrofolate_reductase_inhibitors","/wiki/Category:Pteridines","/wiki/Category:Antifolates","/wiki/Category:Alkynes","/wiki/Category:Antineoplastic_antimetabolites","/wiki/Category:SRI_International","/wiki/Category:Articles_with_changed_CASNo","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/w/index.php?title=Special:UserLogin&returnto=Pralatrexate&type=signup","/w/index.php?title=Special:UserLogin&returnto=Pralatrexate","/wiki/Pralatrexate","/wiki/Talk:Pralatrexate","#","/wiki/Pralatrexate","/w/index.php?title=Pralatrexate&action=edit","/w/index.php?title=Pralatrexate&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf11/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Pralatrexate","/wiki/Special:RecentChangesLinked/Pralatrexate","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Pralatrexate&oldid=563767816","/w/index.php?title=Pralatrexate&action=info","//www.wikidata.org/wiki/Q637059","/w/index.php?title=Special:Cite&page=Pralatrexate&id=563767816","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Pralatrexate","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Pralatrexate&oldid=563767816&writer=rl","/w/index.php?title=Pralatrexate&printable=yes","//hu.wikipedia.org/wiki/Pralatrex%C3%A1t","#","//www.wikidata.org/wiki/Q637059#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Pralatrexate","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf11/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Dihydrofolate reductase inhibitors","Pteridines","Antifolates","Alkynes","Antineoplastic antimetabolites","SRI International"],"headings":["Approval","Mechanism","Discovery","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Pralatrexate.png/300px-Pralatrexate.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf11/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf11/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Intravenous_therapy","Peripheral_T-cell_lymphoma","Food_and_Drug_Administration","Clinical_trials","Antifolate","Folate","Cancer_cells","Antimetabolites","Metabolites","SRI_International","Chemotherapies","Tumor_cells"]}